{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:11:50Z","timestamp":1793459510605,"version":"4.5.0"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0308","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T03:57:02Z","timestamp":1667361422000},"source":"Crossref","is-referenced-by-count":14,"title":["Skin infections due to Panton-Valentine leucocidin\u2013producing S. aureus"],"prefix":"10.3238","author":[{"given":"Rasmus","family":"Leistner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif G.","family":"Hanitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam S.","family":"Stegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Nurjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"10.3238\/arztebl.m2022.0308_ref1","doi-asserted-by":"crossref","unstructured":"Sunderk\u00f6tter C, Becker K, Eckmann C, Graninger W, Kujath P, Sch\u00f6fer H: S2k-Leitlinie Haut- und Weichgewebeinfektionen. Auszug aus „Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen – Update 2018“. J Dtsch Dermatol Ges 2019; 17: 345–71.","DOI":"10.1111\/ddg.13790_g"},{"key":"10.3238\/arztebl.m2022.0308_ref2","doi-asserted-by":"crossref","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al.: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59: e10–e52.","DOI":"10.1093\/cid\/ciu296"},{"key":"10.3238\/arztebl.m2022.0308_ref3","doi-asserted-by":"crossref","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al.: Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41: 1373–406.","DOI":"10.1086\/497143"},{"key":"10.3238\/arztebl.m2022.0308_ref4","doi-asserted-by":"crossref","unstructured":"Kobayashi SD, Malachowa N, DeLeo FR: Pathogenesis of Staphylococcus aureus abscesses. Am J Pathol 2015; 185: 1518–27.","DOI":"10.1016\/j.ajpath.2014.11.030"},{"key":"10.3238\/arztebl.m2022.0308_ref5","doi-asserted-by":"crossref","unstructured":"Saeed K, Gould I, Esposito S, et al.: Panton-valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy. Int J Antimicrob Agents 2018; 51: 16–25.","DOI":"10.1016\/j.ijantimicag.2017.11.002"},{"key":"10.3238\/arztebl.m2022.0308_ref6","doi-asserted-by":"crossref","unstructured":"Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC: The role of the panton-valentine leucocidin toxin in Staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 43–54.","DOI":"10.1016\/S1473-3099(12)70238-4"},{"key":"10.3238\/arztebl.m2022.0308_ref7","doi-asserted-by":"crossref","unstructured":"Nurjadi D, Friedrich-Janicke B, Schafer J, et al.: Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe. Clin Microbiol Infect 2015; 21: 567.e1–e10.","DOI":"10.1016\/j.cmi.2015.01.016"},{"key":"10.3238\/arztebl.m2022.0308_ref8","doi-asserted-by":"crossref","unstructured":"Friesen J, Neuber R, Fuhrmann J, et al.: Panton-valentine leukocidin-positive Staphylococcus aureus in skin and soft tissue infections from primary care patients. Clin Microbiol Infect 2020; 26: 1416.e1–e4.","DOI":"10.1016\/j.cmi.2020.06.029"},{"key":"10.3238\/arztebl.m2022.0308_ref9","doi-asserted-by":"crossref","unstructured":"Lindner AK, Hommes F, Nikolai O, et al.: Imported panton-valentine leucocidin (PVL)-positive Staphylococcus aureus skin infections: patients‘ perspective on quality of life and quality of medical care. J Travel Med 2022; 29: taac047.","DOI":"10.1093\/jtm\/taac047"},{"key":"10.3238\/arztebl.m2022.0308_ref10","doi-asserted-by":"crossref","unstructured":"Hanitsch LG, Kruger R, Hoppe PA, et al.: Outpatient decolonization after recurrent skin infection with Panton-Valentine leukocidin (PVL)-producing S. aureus — the importance of treatment repetition. PloS One 2020; 15: e0231772.","DOI":"10.1371\/journal.pone.0231772"},{"key":"10.3238\/arztebl.m2022.0308_ref11","doi-asserted-by":"crossref","unstructured":"Demos M, McLeod MP, Nouri K: Recurrent furunculosis: a review of the literature. Br J Dermatol 2012; 167: 725–32.","DOI":"10.1111\/j.1365-2133.2012.11151.x"},{"key":"10.3238\/arztebl.m2022.0308_ref12","doi-asserted-by":"crossref","unstructured":"Bocchini CE, Hulten KG, Mason EO Jr., Gonzalez BE, Hammerman WA, Kaplan SL: Panton-valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 2006; 117: 433–40.","DOI":"10.1542\/peds.2005-0566"},{"key":"10.3238\/arztebl.m2022.0308_ref13","doi-asserted-by":"crossref","unstructured":"Ritz N, Curtis N: The role of panton-valentine leukocidin in Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J 2012; 31: 514–8.","DOI":"10.1097\/INF.0b013e31824f18cb"},{"key":"10.3238\/arztebl.m2022.0308_ref14","doi-asserted-by":"crossref","unstructured":"Gillet Y, Tristan A, Rasigade JP, et al.: Prognostic factors of severe community-acquired Staphylococcal pneumonia in France. Eur Respir J 2021; 58: 2004445.","DOI":"10.1183\/13993003.04445-2020"},{"key":"10.3238\/arztebl.m2022.0308_ref15","doi-asserted-by":"crossref","unstructured":"Gillet Y, Vanhems P, Lina G, et al.: Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing panton-valentine leukocidin. Clin Infect Dis 2007; 45: 315–21.","DOI":"10.1086\/519263"},{"key":"10.3238\/arztebl.m2022.0308_ref16","doi-asserted-by":"crossref","unstructured":"Duployez C, Le Guern R, Tinez C, et al.: Panton-valentine leukocidin-secreting Staphylococcus aureus pneumonia complicating COVID-19. Emerg Infect Dis 2020; 26: 1939–41.","DOI":"10.3201\/eid2608.201413"},{"key":"10.3238\/arztebl.m2022.0308_ref17","doi-asserted-by":"crossref","unstructured":"Rentinck MN, Kruger R, Hoppe PA, et al.: Skin infections due to panton-valentine leukocidin (PVL)-producing S. aureus-cost effectiveness of outpatient treatment. PloS One 2021; 16: e0253633.","DOI":"10.1371\/journal.pone.0253633"},{"key":"10.3238\/arztebl.m2022.0308_ref18","doi-asserted-by":"crossref","unstructured":"Nurjadi D, Eichel VM, Tabatabai P, et al.: Surveillance for colonization, transmission, and infection with methicillin-susceptible Staphylococcus aureus in a neonatal intensive care unit. JAMA Netw Open 2021; 4: e2124938.","DOI":"10.1001\/jamanetworkopen.2021.24938"},{"key":"10.3238\/arztebl.m2022.0308_ref19","doi-asserted-by":"crossref","unstructured":"K\u00f6ck R, Mellmann A, Schaumburg F, Friedrich AW, Kipp F, Becker K: The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany. Dtsch Arztebl Int 2011; 108: 761–7.","DOI":"10.3238\/arztebl.2011.0761"},{"key":"10.3238\/arztebl.m2022.0308_ref20","doi-asserted-by":"crossref","unstructured":"Zanger P, Nurjadi D, Schleucher R, et al.: Import and spread of panton-valentine leukocidin-positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics. Clin Infect Dis 2012; 54: 483–92.","DOI":"10.1093\/cid\/cir822"},{"key":"10.3238\/arztebl.m2022.0308_ref21","doi-asserted-by":"crossref","unstructured":"Nurjadi D, Fleck R, Lindner A, et al.: Import of community-associated, methicillin-resistant Staphylococcus aureus to Europe through skin and soft-tissue infection in intercontinental travellers, 2011–2016. Clin Microbiol Infect 2019; 25: 739–46.","DOI":"10.1016\/j.cmi.2018.09.023"},{"key":"10.3238\/arztebl.m2022.0308_ref22","doi-asserted-by":"crossref","unstructured":"Klein S, Menz MD, Zanger P, Heeg K, Nurjadi D: Increase in the prevalence of panton-valentine leukocidin and clonal shift in community-onset methicillin-resistant Staphylococcus aureus causing skin and soft-tissue infections in the Rhine-Neckar Region, Germany, 2012–2016. Int J Antimicrob Agents 2019; 53: 261–7.","DOI":"10.1016\/j.ijantimicag.2018.10.026"},{"key":"10.3238\/arztebl.m2022.0308_ref23","doi-asserted-by":"crossref","unstructured":"Leistner R, Kola A, Gastmeier P, et al.: Pyoderma outbreak among kindergarten families: Association with a panton-valentine leukocidin (PVL)-producing S. aureus strain. PloS One 2017; 12: e0189961.","DOI":"10.1371\/journal.pone.0189961"},{"key":"10.3238\/arztebl.m2022.0308_ref24","doi-asserted-by":"crossref","unstructured":"Wertheim HF, Melles DC, Vos MC, et al.: The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751–62.","DOI":"10.1016\/S1473-3099(05)70295-4"},{"key":"10.3238\/arztebl.m2022.0308_ref25","doi-asserted-by":"crossref","unstructured":"Gillet Y, Dumitrescu O, Tristan A, et al.: Pragmatic management of panton-valentine leukocidin-associated staphylococcal diseases. Int J Antimicrob Agents 2011; 38: 457–64.","DOI":"10.1016\/j.ijantimicag.2011.05.003"},{"key":"10.3238\/arztebl.m2022.0308_ref26","doi-asserted-by":"crossref","unstructured":"Pittet D, Allegranzi B, Sax H, et al.: Evidence-based model for hand transmission during patient care and the role of improved practices. Lancet Infect Dis 2006; 6: 641–52.","DOI":"10.1016\/S1473-3099(06)70600-4"},{"key":"10.3238\/arztebl.m2022.0308_ref27","doi-asserted-by":"crossref","unstructured":"Talan DA, Mower WR, Krishnadasan A, et al.: Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 2016; 374: 823–32.","DOI":"10.1056\/NEJMoa1507476"},{"key":"10.3238\/arztebl.m2022.0308_ref28","doi-asserted-by":"crossref","unstructured":"Moran GJ, Abrahamian FM, Lovecchio F, Talan DA: Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. J Emerg Med 2013; 44: e397–e412.","DOI":"10.1016\/j.jemermed.2012.11.050"},{"key":"10.3238\/arztebl.m2022.0308_ref29","doi-asserted-by":"crossref","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al.: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 2014; 59: 147–59.","DOI":"10.1093\/cid\/ciu444"},{"key":"10.3238\/arztebl.m2022.0308_ref30","doi-asserted-by":"crossref","unstructured":"Septimus EJ, Schweizer ML: Decolonization in prevention of health care-associated infections. Clin Microbiol Rev 2016; 29: 201–22.","DOI":"10.1128\/CMR.00049-15"},{"key":"10.3238\/arztebl.m2022.0308_ref31","doi-asserted-by":"crossref","unstructured":"Huang SS, Singh R, McKinnell JA, et al.: Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med 2019; 380: 638–50.","DOI":"10.1056\/NEJMoa1716771"},{"key":"10.3238\/arztebl.m2022.0308_ref32","doi-asserted-by":"crossref","unstructured":"Huang SS, Septimus E, Kleinman K, et al.: Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 2255–65.","DOI":"10.1056\/NEJMoa1207290"},{"key":"10.3238\/arztebl.m2022.0308_ref33","doi-asserted-by":"crossref","unstructured":"Climo MW, Yokoe DS, Warren DK, et al.: Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368: 533–42.","DOI":"10.1056\/NEJMoa1113849"},{"key":"10.3238\/arztebl.m2022.0308_ref34","doi-asserted-by":"crossref","unstructured":"Wisgrill L, Zizka J, Unterasinger L, et al.: Active surveillance cultures and targeted decolonization are associated with reduced methicillin-susceptible Staphylococcus aureus infections in VLBW infants. Neonatology 2017; 112: 267–73.","DOI":"10.1159\/000477295"},{"key":"10.3238\/arztebl.m2022.0308_ref35","doi-asserted-by":"crossref","unstructured":"Bode LG, Kluytmans JA, Wertheim HF, et al.: Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9–17.","DOI":"10.1056\/NEJMoa0808939"},{"key":"10.3238\/arztebl.m2022.0308_ref36","doi-asserted-by":"crossref","unstructured":"Denkel LA, Schwab F, Clausmeyer J, et al.: Effect of antiseptic bathing with chlorhexidine or octenidine on central line-associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial. Clin Microbiol Infect 2022; 28: 825–31.","DOI":"10.1016\/j.cmi.2021.12.023"},{"key":"10.3238\/arztebl.m2022.0308_ref37","doi-asserted-by":"crossref","unstructured":"Uhlemann AC, Dordel J, Knox JR, et al.: Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci USA 2014; 111: 6738–43.","DOI":"10.1073\/pnas.1401006111"},{"key":"10.3238\/arztebl.m2022.0308_ref38","doi-asserted-by":"crossref","unstructured":"Gopal Rao G, Batura R, Nicholl R, et al.: Outbreak report of investigation and control of an outbreak of panton-valentine leukocidin-positive methicillin-sensitive Staphylococcus aureus (PVL-MSSA) infection in neonates and mothers. BMC Infect Dis 2019; 19: 178.","DOI":"10.1186\/s12879-019-3802-0"},{"key":"10.3238\/arztebl.m2022.0308_ref39","doi-asserted-by":"crossref","unstructured":"Balamohan A, Beachy J, Kohn N, Rubin LG: The effect of routine surveillance and decolonization on the rate of Staphylococcus aureus infections in a level IV neonatal intensive care unit. J Perinatol 2020; 40: 1644–51.","DOI":"10.1038\/s41372-020-0755-5"},{"key":"10.3238\/arztebl.m2022.0308_ref40","doi-asserted-by":"crossref","unstructured":"Kotloff KL, Shirley DT, Creech CB, et al.: Mupirocin for Staphylococcus aureus decolonization of infants in neonatal intensive care units. Pediatrics 2019; 143: e20181565.","DOI":"10.1542\/peds.2018-1565"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T18:31:16Z","timestamp":1678473076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0308","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}